219 related articles for article (PubMed ID: 17348438)
21. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
22. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer.
Ichikawa D; Koike H; Ikoma H; Ikoma D; Tani N; Otsuji E; Kitamura K; Yamagishi H
Anticancer Res; 2004; 24(4):2477-81. PubMed ID: 15330201
[TBL] [Abstract][Full Text] [Related]
23. Correlation between serum DNA methylation and prognosis in gastric cancer patients.
Ikoma H; Ichikawa D; Koike H; Ikoma D; Tani N; Okamoto K; Ochiai T; Ueda Y; Otsuji E; Yamagishi H
Anticancer Res; 2006; 26(3B):2313-6. PubMed ID: 16821608
[TBL] [Abstract][Full Text] [Related]
24. Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications.
Hu XC; Wong IH; Chow LW
Oncol Rep; 2003; 10(6):1811-5. PubMed ID: 14534701
[TBL] [Abstract][Full Text] [Related]
25. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
26. [DNA methylation status of RARβ2 and p16(INK4α) in peripheral blood and tumor tissue in patients with esophageal squamous cell carcinoma].
Wang CC; Mao WM; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):441-5. PubMed ID: 22967446
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility.
Liu Z; Jiang M; Zhao J; Ju H
Clin Cancer Res; 2007 May; 13(10):2992-7. PubMed ID: 17505001
[TBL] [Abstract][Full Text] [Related]
28. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
[TBL] [Abstract][Full Text] [Related]
29. Molecular detection of free cancer cells in pleural lavage fluid from esophageal cancer patients.
Natsugoe S; Tokuda K; Matsumoto M; Okumura H; Nakajo A; Takatori H; Nakashima H; Ishigami S; Takao S; Aikou T
Int J Mol Med; 2003 Nov; 12(5):771-5. PubMed ID: 14533008
[TBL] [Abstract][Full Text] [Related]
30. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
[TBL] [Abstract][Full Text] [Related]
31. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers.
Lukyanchuk VV; Friess H; Kleeff J; Osinsky SP; Ayuni E; Candinas D; Roggo A
Anticancer Res; 2003; 23(3B):2711-6. PubMed ID: 12894563
[TBL] [Abstract][Full Text] [Related]
32. Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis.
Kaganoi J; Shimada Y; Kano M; Okumura T; Watanabe G; Imamura M
Br J Surg; 2004 Aug; 91(8):1055-60. PubMed ID: 15286970
[TBL] [Abstract][Full Text] [Related]
33. Circulating tumor cells detected by reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA: distinguishing follicular thyroid carcinoma from adenoma.
Sato T; Harao M; Nakano S; Jotsuka T; Suda N; Yamashita J
Surgery; 2005 May; 137(5):552-8. PubMed ID: 15855928
[TBL] [Abstract][Full Text] [Related]
34. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
[TBL] [Abstract][Full Text] [Related]
35. Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study.
Schmiemann V; Böcking A; Kazimirek M; Onofre AS; Gabbert HE; Kappes R; Gerharz CD; Grote HJ
Clin Cancer Res; 2005 Nov; 11(21):7728-34. PubMed ID: 16278393
[TBL] [Abstract][Full Text] [Related]
36. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer.
Tomita H; Ichikawa D; Ikoma D; Sai S; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Otsuji E
Anticancer Res; 2007; 27(4C):2737-41. PubMed ID: 17695440
[TBL] [Abstract][Full Text] [Related]
37. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
38. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
[TBL] [Abstract][Full Text] [Related]
39. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.
Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762
[TBL] [Abstract][Full Text] [Related]
40. Carcinoembryonic antigen messenger RNA expression in blood predicts recurrence in esophageal cancer.
Setoyama T; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Ishigami S; Owaki T; Takao S; Aikou T
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5972-7. PubMed ID: 17062668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]